Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

NCT00003702 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

NETWORK

Sponsor class

Conditions

Good Prognosis Metastatic Gestational Trophoblastic Tumor
Hydatidiform Mole
Non-Metastatic Gestational Trophoblastic Tumor
Uterine Corpus Choriocarcinoma

Interventions

BIOLOGICAL: Dactinomycin
DRUG: Methotrexate

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]
[object Object]